Literature DB >> 24239579

The influence of lipid composition and surface charge on biodistribution of intact liposomes releasing from hydrogel-embedded vesicles.

A Alinaghi1, M R Rouini2, F Johari Daha3, H R Moghimi4.   

Abstract

Mixed drug delivery systems possess advantages over discrete systems, and can be used as a strategy to design more effective formulations. They are more valuable if the embedded particles perform well, rather than using drugs that have been affected by the surrounding vehicle. In order to address this concept, different liposomes have been incorporated into hydrogel to evaluate the potential effect on the controlled release of liposomes. Radiolabeled liposomes, with respect to different acyl chain lengths (DMPC, DPPC, or DSPC) and charges (neutral, negative [DSPG], or positive [DOTAP]) were integrated into chitosan-glycerophosphate. The results obtained from the biodistribution showed that the DSPC liposomes had the highest area under the curve (AUC) values, both in the blood (206.5%ID/gh(-1)) and peritoneum (622.3%ID/gh(-1)), when compared to the DPPC and DMPC formulations, whether in liposomal hydrogel or dispersion. Interesting results were observed in that the hydrogel could reverse the peritoneal retention of negatively charged liposomes, increasing to 8 times its AUC value, to attain the highest amount among all formulations. The interactions between the liposomes and chitosan-glycerophosphate, confirmed by the Fourier transform infrared (FTIR) spectra as shifted characteristic peaks, were observed in the combined systems. Overall, the hydrogel could control the release of intact liposomes, which could be manipulated by both the liposome type and interactions between the two vehicles.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Keywords:  Biodistribution; IP injection; In situ forming liposomal hydrogel; Liposome charge; Liposome composition; Radiolabeled liposomes

Mesh:

Substances:

Year:  2013        PMID: 24239579     DOI: 10.1016/j.ijpharm.2013.11.011

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Co-Delivery of Ciprofloxacin and Colistin in Liposomal Formulations with Enhanced In Vitro Antimicrobial Activities against Multidrug Resistant Pseudomonas aeruginosa.

Authors:  Shaoning Wang; Shihui Yu; Yuwei Lin; Peizhi Zou; Guihong Chai; Heidi H Yu; Hasini Wickremasinghe; Nivedita Shetty; Junhong Ling; Jian Li; Qi Tony Zhou
Journal:  Pharm Res       Date:  2018-08-09       Impact factor: 4.200

2.  Nano-multilamellar lipid vesicles (NMVs) enhance protective antibody responses against Shiga toxin (Stx2a) produced by enterohemorrhagic Escherichia coli strains (EHEC).

Authors:  M J Rodrigues-Jesus; W L Fotoran; R M Cardoso; K Araki; G Wunderlich; Luís C S Ferreira
Journal:  Braz J Microbiol       Date:  2018-12-06       Impact factor: 2.476

3.  A Study of Liposomal Formulations to Improve the Delivery of Aquated Cisplatin to a Multidrug Resistant Tumor.

Authors:  Yucheng Zhao; Jonathan P May; I-Wen Chen; Elijus Undzys; Shyh-Dar Li
Journal:  Pharm Res       Date:  2015-05-12       Impact factor: 4.200

Review 4.  Barriers to Liposomal Gene Delivery: from Application Site to the Target.

Authors:  Mostafa Saffari; Hamid Reza Moghimi; Crispin R Dass
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

5.  Liposomal delivery and polyethylene glycol-liposomal oxaliplatin for the treatment of colorectal cancer (Review).

Authors:  Chuang Yang; Zhong-Xue Fu
Journal:  Biomed Rep       Date:  2014-03-12

6.  Effect of Charge on Separation of Liposomes upon Stagnation.

Authors:  Mahsa Narenji; Mohammad Reza Talaee; Hamid Reza Moghimi
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.